Amperos Health raises $16m Series A led by Bessemer
Bessemer Venture Partners leads the financing as Amperos launches its AI-based denial-management offering and expands provider coverage.
Series A alongside a product launch
Amperos Health announced a $16 million Series A on April 22, 2026, led by Bessemer Venture Partners with participation from Uncork Capital and Neo. The financing accompanied the launch of its AI-based denial-management and insurance-revenue recovery platform, following a $4.2 million seed announcement in June 2025.
Scaling beyond the existing provider base
Amperos said it had served more than 3,000 clinical locations across all 50 US states. The company plans to use the new capital to reach additional providers, expand analytics and develop capabilities for other revenue-cycle workflows. That extension beyond denial recovery is the next product-development step described with the financing.
Use of funds
Expand provider coverage
Extend analytics capabilities
Develop additional revenue-cycle workflows